School of Pharmacy : Reich Reuven

1.

Onallah H, Mannully ST, Davidson B, Reich R. Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D. International Journal of Molecular Sciences [Internet]. 2022;23(21). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85141570733&doi=10.3390%252fijms232113286&partnerID=40&md5=9fde8a2d1c06294689b8133f38e1398c

2.

Davidson B, Reich R. Pathophysiology roles and translational opportunities of miRNAs in ovarian cancer [Internet]. MicroRNA in Human Malignancies. 2022. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130132215&doi=10.1016%252fB978-0-12-822287-4.00004-9&partnerID=40&md5=ce3d75d7ef3e5d6b50959d5b7fa4827a

3.

Catane LJ, Moshel O, Smith Y, Davidson B, Reich R. Splice‐variant knock‐out of tgfβ receptors perturbates the proteome of ovarian carcinoma cells. International Journal of Molecular Sciences [Internet]. 2021;22(23). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119672900&doi=10.3390%252fijms222312647&partnerID=40&md5=4798d652d0c24ffe4217d8d04188f886

4.

Filippov-Levy N, Davidson B, Reich R. The Biological Role of the Long Non-coding RNA LINK-A in Ovarian Carcinoma. Anticancer Research [Internet]. 2020;40(12):6677–84. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097483040&doi=10.21873%252fanticanres.14691&partnerID=40&md5=63e1e28b4bb914b80ba04068138126af

5.

Filippov-Levy N, Reich R, Davidson B. The biological and clinical role of the long non-coding rna loc642852 in ovarian carcinoma. International Journal of Molecular Sciences [Internet]. 2020;21(15):1–15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088586008&doi=10.3390%252fijms21155237&partnerID=40&md5=1b8b7a53bfd49b9fb5c36edbf714728b

6.

Chehover M, Reich R, Davidson B. Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma. Virchows Archiv [Internet]. 2020;477(2):249–58. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077281945&doi=10.1007%252fs00428-019-02737-z&partnerID=40&md5=dd2a705418db3de0d8dd4e3a4e893a98

7.

Stern-Tal D, Achache H, Jacobs Catane L, Reich R, Tavor Re’em T. Novel 3D embryo implantation model within macroporous alginate scaffolds. Journal of Biological Engineering [Internet]. 2020;14(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087487514&doi=10.1186%252fs13036-020-00240-7&partnerID=40&md5=68ffccca56ee84d9f71c9a4dabd42ede

8.

Broner EC, Onallah H, Tavor Re’Em T, Davidson B, Reich R. Role of the Exosome Secretion Machinery in Ovarian Carcinoma: In Vitro and in Vivo Models. Journal of Oncology [Internet]. 2020;2020. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086343045&doi=10.1155%252f2020%252f4291827&partnerID=40&md5=3815a68f644e71052872c7f74afba03b

9.

Sherman-Samis M, Onallah H, Holth A, Reich R, Davidson B. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma. Gynecologic Oncology [Internet]. 2019;153(3):651–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063108375&doi=10.1016%252fj.ygyno.2019.03.099&partnerID=40&md5=20415c0406af8be48a7ddb499e045815

10.

Onallah H, Davidson B, Reich R. Diverse Effects of Lysophosphatidic Acid Receptors on Ovarian Cancer Signaling Pathways. Journal of Oncology [Internet]. 2019;2019. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073075861&doi=10.1155%252f2019%252f7547469&partnerID=40&md5=bf9cf0f5741b04fa727d3a79c4bb7fcd

11.

Onallah H, Catane LJ, Tropé CG, Hetland Falkenthal TE, Reich R, Davidson B. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma. Virchows Archiv [Internet]. 2018;473(4):463–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050314426&doi=10.1007%252fs00428-018-2418-x&partnerID=40&md5=d0cc3c31e8b57a45e6278d5a7a213dab

12.

Filippov-Levy N, Cohen-Schussheim H, Tropé CG, Hetland Falkenthal TE, Smith Y, Davidson B, et al. Expression and clinical role of long non-coding RNA in high-grade serous carcinoma. Gynecologic Oncology [Internet]. 2018;148(3):559–66. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039970952&doi=10.1016%252fj.ygyno.2018.01.004&partnerID=40&md5=8917fa2f581ed1cc63ef0bd4059571b7

13.

Gutgold N, Davidson B, Catane LJ, Holth A, Hellesylt E, Tropé CG, et al. TGFβ splicing and canonical pathway activation in high-grade serous carcinoma. Virchows Archiv [Internet]. 2017;470(6):665–78. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018825138&doi=10.1007%252fs00428-017-2127-x&partnerID=40&md5=f833ab460e59212b5caa9046e43198fb

14.

Harel-Dassa K, Yedgar S, Tropé CG, Davidson B, Reich R. Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma. Human Pathology [Internet]. 2017;62:115–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015010849&doi=10.1016%252fj.humpath.2016.12.023&partnerID=40&md5=d7eb7cde1ecce569f23e13e8a497bf57

15.

Broner EC, Tropé CG, Reich R, Davidson B. TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma. Human Pathology [Internet]. 2017;60:180–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007140133&doi=10.1016%252fj.humpath.2016.10.017&partnerID=40&md5=7915eb5cd32d0e788875c9ad7a018f08

16.

Horwitz V, Davidson B, Stern D, Tropé CG, Re’Em TT, Reich R. Ezrin is associated with disease progression in ovarian carcinoma. PLoS ONE [Internet]. 2016;11(9). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84990945313&doi=10.1371%252fjournal.pone.0162502&partnerID=40&md5=6301e393f10387a8cb128d1570c802a7

17.

Nymoen DA, Slipicevic A, Holth A, Emilsen E, Falkenthal TEH, Tropé CG, et al. Mir-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma. Human Pathology [Internet]. 2016;54:74–81. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84971325330&doi=10.1016%252fj.humpath.2016.03.010&partnerID=40&md5=a71e4d61b473b76b697404d7b9d88bdb

18.

Ravid Y, Formanski M, Smith Y, Reich R, Davidson B. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures. Gynecologic Oncology [Internet]. 2016;140(3):512–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959270481&doi=10.1016%252fj.ygyno.2016.01.001&partnerID=40&md5=078473004be502e319cb12ccd21034c3

19.

Davidson B, Holth A, Hellesylt E, Hadar R, Katz B, Tropé CG, et al. HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival. Human Pathology [Internet]. 2016;48:95–101. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954403085&doi=10.1016%252fj.humpath.2015.09.027&partnerID=40&md5=c698587466fe2c8b9b102fc38ef158e3

20.

Reich R, Hoffman A, Suresh RR, Shai O, Frant J, Maresca A, et al. Carbamoylphosphonates inhibit autotaxin and metastasis formation in vivo. Journal of Enzyme Inhibition and Medicinal Chemistry [Internet]. 2015;30(5):767–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940663159&doi=10.3109%252f14756366.2014.968146&partnerID=40&md5=d18e27665f58b9ba307c2e730ea1e60d

21.

Katz B, Tropé CG, Reich R, Davidson B. MicroRNAs in Ovarian Cancer. Human Pathology [Internet]. 2015;46(9):1245–56. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940459782&doi=10.1016%252fj.humpath.2015.06.013&partnerID=40&md5=055a47e607696cf4b1e024f5c6f7a0f8

22.

Veerendhar A, Cohen S, Frant J, Supuran CT, Reich R, Breuer E. Synthesis of Enantiomeric Aminoalkylcarbamoylphosphonates and Their Evaluation as Dual-Action Anticancer MMP and Carbonic Anhydrase Inhibitors. Heteroatom Chemistry [Internet]. 2015;26(4):257–69. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027947346&doi=10.1002%252fhc.21256&partnerID=40&md5=ddf6bf012294f2804d2d1bafe83130d2

23.

Maimon A, Mogilevsky M, Shilo A, Golan-Gerstl R, Obiedat A, Ben-Hur V, et al. Mnk2 Alternative Splicing Modulates the p38-MAPK Pathway and Impacts Ras-Induced Transformation. Cell Reports [Internet]. 2014;7(2):501–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899619503&doi=10.1016%252fj.celrep.2014.03.041&partnerID=40&md5=cad91982063d5d73dd86453b5915ec54

24.

Reich R, Supuran CT, Breuer E. Tumor microenvironment as target in cancer therapy. Annual Reports in Medicinal Chemistry [Internet]. 2014;49:269–84. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907557826&doi=10.1016%252fB978-0-12-800167-7.00017-1&partnerID=40&md5=84dc373c4f3a62eb37a8325655680f13

25.

Vaksman O, Tropé C, Davidson B, Reich R. Exosome-derived miRNAs and ovarian carcinoma progression. Carcinogenesis [Internet]. 2014;35(9):2113–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906834990&doi=10.1093%252fcarcin%252fbgu130&partnerID=40&md5=2d2370d4bda1e672b387f9645d823431

26.

Davidson B, Trope CG, Reich R. The role of the tumor stroma in ovarian cancer. Frontiers in Oncology [Internet]. 2014;4 MAY. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904617133&doi=10.3389%252ffonc.2014.00104&partnerID=40&md5=acdd0407bc39853e94f9766bf5b435d0

27.

Davidson B, Rosenfeld YBZ, Holth A, Hellesylt E, Tropé CG, Reich R, et al. VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival. Human Pathology [Internet]. 2014;45(7):1520–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903219135&doi=10.1016%252fj.humpath.2014.03.005&partnerID=40&md5=11cdda6e55ba4fdd75c75d758746f9f7

28.

Davidson B, Nymoen DA, Elgaaen BV, Staff AC, Tropé CG, Kærn J, et al. BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma. Virchows Archiv [Internet]. 2014;464(6):701–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902313256&doi=10.1007%252fs00428-014-1577-7&partnerID=40&md5=ac23a5f23d6d90a41394c3b64d7c3be5

29.

Davidson B, Tropé CG, Reich R. The clinical and diagnostic role of microRNAs in ovarian carcinoma. Gynecologic Oncology [Internet]. 2014;133(3):640–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901655594&doi=10.1016%252fj.ygyno.2014.03.575&partnerID=40&md5=abddec399436ec9f4b63adf57bc0d67b

30.

Vaksman O, Davidson B, Tropé C, Reich R. Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases. Human Pathology [Internet]. 2013;44(12):2677–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888050237&doi=10.1016%252fj.humpath.2013.07.009&partnerID=40&md5=2fc636b5bfa530d2e4ab531356f85adc

31.

Davidson B, Smith Y, Nesland JM, Kærn J, Reich R, Tropè CG. Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion. Human Pathology [Internet]. 2013;44(11):2449–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885634420&doi=10.1016%252fj.humpath.2013.06.003&partnerID=40&md5=15640f39c6231901b01961546c7e605f

32.

Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, et al. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival. Gynecologic Oncology [Internet]. 2013;129(2):358–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876285605&doi=10.1016%252fj.ygyno.2013.02.021&partnerID=40&md5=77feae64c8055632a7f48f6893cbb14b

33.

Sebban S, Golan-Gerstl R, Karni R, Vaksman O, Davidson B, Reich R. Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer. Clinical and Experimental Metastasis [Internet]. 2013;30(1):103–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872682606&doi=10.1007%252fs10585-012-9514-0&partnerID=40&md5=642e0d282cb1e44d03d59f192b6a9318

34.

Davidson B, Tropé CG, Reich R. Epithelial-mesenchymal transition in ovarian carcinoma. Frontiers in Oncology [Internet]. 2012;2(APR). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870233792&doi=10.3389%252ffonc.2012.00033&partnerID=40&md5=3ca5264381890d0a25ed051787b598b4

35.

Vaksman O, Hetland TE, Trope’ CG, Reich R, Davidson B. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. Human Pathology [Internet]. 2012;43(11):2062–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867889748&doi=10.1016%252fj.humpath.2012.02.016&partnerID=40&md5=14ac6586b6bd866f917763f7e4e2b8c3

36.

Momic T, Cohen G, Reich R, Arlinghaus FT, Eble JA, Marcinkiewicz C, et al. Vixapatin (VP12), a C-type lectin-protein from Vipera xantina palestinae venom: Characterization as a novel anti-angiogenic compound. Toxins [Internet]. 2012;4(10):862–77. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868365023&doi=10.3390%252ftoxins4100862&partnerID=40&md5=1f80b1b2b38ab0d291670cd0e728ee90

37.

Reich R, Hoffman A, Veerendhar A, Maresca A, Innocenti A, Supuran CT, et al. Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment(1). Journal of Medicinal Chemistry [Internet]. 2012;55(17):7875–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866307412&doi=10.1021%252fjm300981b&partnerID=40&md5=878e212ec4cfb049315e520849d5e7c2

38.

Konstantinovsky S, Davidson B, Reich R. Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids. Clinical and Experimental Metastasis [Internet]. 2012;29(6):527–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863725509&doi=10.1007%252fs10585-012-9468-2&partnerID=40&md5=08fd6b9befb5e0f13b355bb6dba0dfdc

39.

Brenne K, Nymoen DA, Reich R, Davidson B. PRAME (preferentially expressed antigen of melanoma) is a novel marker for differentiating serous carcinoma from malignant mesothelioma. American Journal of Clinical Pathology [Internet]. 2012;137(2):240–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856401870&doi=10.1309%252fAJCPGA95KVSAUDMF&partnerID=40&md5=227d029b6786800a5f3e734546a4a60f

40.

Weiss I, Trope CG, Reich R, Davidson B. Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure. International Journal of Molecular Sciences [Internet]. 2012;13(10):12925–38. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867777179&doi=10.3390%252fijms131012925&partnerID=40&md5=dfed79d9d5ed956016e1db6c78bbf802

41.

Frant J, Veerendhar A, Chernilovsky T, Nedvetzki S, Vaksman O, Hoffman A, et al. Orally Active, Antimetastatic, Nontoxic Diphenyl Ether-Derived Carbamoylphosphonate Matrix Metalloproteinase Inhibitors. ChemMedChem [Internet]. 2011;6(8):1471–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960694567&doi=10.1002%252fcmdc.201100153&partnerID=40&md5=5b843b8f966a533907fb2a28ddcd8539

42.

Yuan Y, Leszczynska M, Konstantinovsky S, Tropé CG, Reich R, Davidson B. Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors. Diagnostic Cytopathology [Internet]. 2011;39(8):562–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960402692&doi=10.1002%252fdc.21424&partnerID=40&md5=dc275453f65955a7f9ddff9c95b1a21f

43.

Vaksman O, Stavnes HT, Kærn J, Trope CG, Davidson B, Reich R. miRNA profiling along tumour progression in ovarian carcinoma. Journal of Cellular and Molecular Medicine [Internet]. 2011;15(7):1593–602. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959480974&doi=10.1111%252fj.1582-4934.2010.01148.x&partnerID=40&md5=30f3d9c46a3574451af32023098dd008

44.

Revel A, Achache H, Stevens J, Smith Y, Reich R. MicroRNAs are associated with human embryo implantation defects. Human Reproduction [Internet]. 2011;26(10):2830–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052906260&doi=10.1093%252fhumrep%252fder255&partnerID=40&md5=9ce9e04fce9209aca32d71d05aa23693

45.

Reich R, Hadar S, Davidson B. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma. International Journal of Molecular Sciences [Internet]. 2011;12(2):1133–45. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952256593&doi=10.3390%252fijms12021133&partnerID=40&md5=4bd7ffc9784309128e92452b4308b3af

46.

Davidson B, Reich R, Trope CG, Wang TL, Shih IM. New determinates of disease progression and outcome in metastatic ovarian carcinoma. Histology and Histopathology [Internet]. 2010;25(12):1591–609. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952197556&partnerID=40&md5=23d21408b0f071d9fbc8fe1d5a2cc654

47.

Achache H, Tsafrir A, Prus D, Reich R, Revel A. Defective endometrial prostaglandin synthesis identified in patients with repeated implantation failure undergoing in vitro fertilization. Fertility and Sterility [Internet]. 2010;94(4):1271–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956190790&doi=10.1016%252fj.fertnstert.2009.07.1668&partnerID=40&md5=b1599fb13694fe5c92ebee00715e4991

48.

Lubetzky R, Mandel D, Mimouni FB, Herman L, Reich R, Reif S. MMP-2 and MMP-9 and their tissue inhibitor in preterm human milk. Journal of Pediatric Gastroenterology and Nutrition [Internet]. 2010;51(2):210–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955228840&doi=10.1097%252fMPG.0b013e3181d345b8&partnerID=40&md5=a7284197b287fcf4ee0869c03c8a13df

49.

Bunkholt Elstrand M, Dong HP, Ødegaard E, Holth A, Elloul S, Reich R, et al. Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma. Human Pathology [Internet]. 2010;41(6):794–804. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951975662&doi=10.1016%252fj.humpath.2009.09.017&partnerID=40&md5=7ee2a5bab9b872dc5d71608c5f2dcdaa

50.

Elloul S, Vaksman O, Stavnes HT, Trope CG, Davidson B, Reich R. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions. Clinical and Experimental Metastasis [Internet]. 2010;27(3):161–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950866305&doi=10.1007%252fs10585-010-9315-2&partnerID=40&md5=1eb930cbc6babcb6c608e70f994ddefb

51.

Veerendhar A, Reich R, Breuer E. Phosphorus based inhibitors of matrix metalloproteinases. Comptes Rendus Chimie [Internet]. 2010;13(8–9):1191–202. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956614709&doi=10.1016%252fj.crci.2010.07.003&partnerID=40&md5=927178b7179782b2e5bc76b9bb25f648

52.

Shatz M, Lustig G, Reich R, Liscovitch M. Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells. Experimental Cell Research [Internet]. 2010;316(10):1748–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953230423&doi=10.1016%252fj.yexcr.2010.02.006&partnerID=40&md5=2d1072e1ee18f9768938dab600f02c67

53.

Kohan M, Puxeddu I, Reich R, Levi-Schaffer F, Berkman N. Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts. Annals of Allergy, Asthma and Immunology [Internet]. 2010;104(1):66–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-76749157385&doi=10.1016%252fj.anai.2009.11.003&partnerID=40&md5=fc194878d7aff880fd6ea0f0285df639

54.

Davidson B, Hadar R, Stavnes HT, Trope’ CG, Reich R. Expression of the peroxisome proliferator-activated receptors-α, -β, and -γ in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Human Pathology [Internet]. 2009;40(5):705–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-64449086798&doi=10.1016%252fj.humpath.2008.09.019&partnerID=40&md5=60dd4277c8e5f7d05c0ca854d58b661a

55.

Koler M, Achache H, Tsafrir A, Smith Y, Revel A, Reich R. Disrupted gene pattern in patients with repeated in vitro fertilization (IVF) failure. Human Reproduction [Internet]. 2009;24(10):2541–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349451755&doi=10.1093%252fhumrep%252fdep193&partnerID=40&md5=68f9b21d8b8b3ec68bc5be18d7f5da7a

56.

Sebban S, Davidson B, Reich R. Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities. Virchows Archiv [Internet]. 2009;454(1):71–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-57749201378&doi=10.1007%252fs00428-008-0694-6&partnerID=40&md5=962e184cc2e8e7afcabe0c49994a99e0

57.

Rayhman O, Klipper E, Muller L, Davidson B, Reich R, Meidan R. Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells. Cancer Research [Internet]. 2008;68(22):9265–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-56449108554&doi=10.1158%252f0008-5472.CAN-08-2093&partnerID=40&md5=d2962756037165d5b7e485daa0c93ac8

58.

Ravid D, Chuderland D, Landsman L, Lavie Y, Reich R, Liscovitch M. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Experimental Cell Research [Internet]. 2008;314(15):2762–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-50049106405&doi=10.1016%252fj.yexcr.2008.06.004&partnerID=40&md5=1cdbede5dc294da8c34cb2d24abb1e97

59.

Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, et al. Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor - Synthesis and pharmacodynamic and pharmacokinetic analysis (Journal of Medicinal Chemistry (2008) 51, (1408)). Journal of Medicinal Chemistry [Internet]. 2008;51(14):4357–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-47749121762&doi=10.1021%252fjm800674s&partnerID=40&md5=48748f7eccff47283f05125fdcca11ff

60.

Kleinberg L, Holth A, Trope CG, Reich R, Davidson B. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival. Human Pathology [Internet]. 2008;39(5):747–57. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-42949113594&doi=10.1016%252fj.humpath.2007.10.002&partnerID=40&md5=91875722242fe4d8174e56a8329cdef6

61.

Beylis I, Frant J, Mussai N, Reich R, Breuer E. Carbamoylphosphonates part 7. An efficient method for the synthesis of hindered carbamoylphosphonates using 4-nitrophenoxycarbonylphosphonate diesters. Tetrahedron Letters [Internet]. 2008;49(18):2875–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-41349111232&doi=10.1016%252fj.tetlet.2008.03.036&partnerID=40&md5=fec3471a6bda6180a0254ff9e17b698b

62.

Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, et al. Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor-synthesis and pharmacodynamic and pharmacokinetic analysis. Journal of Medicinal Chemistry [Internet]. 2008;51(5):1406–14. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-41349106390&doi=10.1021%252fjm701087n&partnerID=40&md5=23b2604d43c65f6a40b88ee3a06678df

63.

Gorovetz M, Schwob O, Krimsky M, Yedgar S, Reich R. MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2. Frontiers in Bioscience [Internet]. 2008;13(5):1917–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-38449114271&doi=10.2741%252f2811&partnerID=40&md5=1602ea7d65bccb7883f25feb90ef13b3

64.

Davidson B, Hadar R, Schlossberg A, Sternlicht T, Slipicevic A, Skrede M, et al. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Human Pathology [Internet]. 2008;39(1):87–95. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-36849096091&doi=10.1016%252fj.humpath.2007.05.014&partnerID=40&md5=66f87a85a3fd266838adf96b328010cf

65.

Davidson B, Shafat I, Risberg B, Ilan N, Trope’ CG, Vlodavsky I, et al. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Gynecologic Oncology [Internet]. 2007;104(2):311–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846519554&doi=10.1016%252fj.ygyno.2006.08.045&partnerID=40&md5=6c9f18eb56721ba005544e3de5980957

66.

Davidson B, Tropé CG, Reich R. Cell adhesion and matrixassociated proteins in ovarian carcinoma [Internet]. Prognostic and Predictive Factors in Gynecologic Cancers. 2007. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056518628&partnerID=40&md5=2e8e69e92fdb6de995fecb453c2c2d89

67.

Gorovetz M, Baekelandt M, Berner A, Trope’ CG, Davidson B, Reich R. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gynecologic Oncology [Internet]. 2006;103(3):831–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33751528924&doi=10.1016%252fj.ygyno.2006.06.042&partnerID=40&md5=95a30a213ae9f84963eecfc2527cbae7

68.

Sivertsen S, Hadar R, Elloul S, Vintman L, Bedrossian C, Reich R, et al. Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer [Internet]. 2006;54(3):309–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750987299&doi=10.1016%252fj.lungcan.2006.08.010&partnerID=40&md5=66650ad61bcf489a13d586e1122508e3

69.

Elloul S, Silins I, Tropé CG, Benshushan A, Davidson B, Reich R. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Archiv [Internet]. 2006;449(5):520–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750866948&doi=10.1007%252fs00428-006-0274-6&partnerID=40&md5=12d26d4739839cf938ec113ded18eab0

70.

Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MTP, Bassarova A, Kvalheim G, et al. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Gynecologic Oncology [Internet]. 2006;102(3):453–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748609676&doi=10.1016%252fj.ygyno.2006.01.034&partnerID=40&md5=073e5722117e43200c6dc159dae68f14

71.

Cohen-Sela E, Rosenzweig O, Gao J, Epstein H, Gati I, Reich R, et al. Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. Journal of Controlled Release [Internet]. 2006;113(1):23–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33744535630&doi=10.1016%252fj.jconrel.2006.03.010&partnerID=40&md5=5e473c53fd5454b794e1508443217afb

72.

Rosenzweig T, Ziv-Av A, Xiang C, Lu W, Cazacu S, Taler D, et al. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Cancer Research [Internet]. 2006;66(8):4139–48. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646237566&doi=10.1158%252f0008-5472.CAN-05-2851&partnerID=40&md5=9433ba698ca52311659e01c4a6895da7

73.

Alpert E, Gruzman A, Lardi-Studler B, Cohen G, Reich R, Sasson S. Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin-and AMPKα-independent manner. Diabetologia [Internet]. 2006;49(3):562–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33244485463&doi=10.1007%252fs00125-005-0122-2&partnerID=40&md5=135ed8a2bf29dd03f13e3ddae9f7a633

74.

Ødegaard E, Staff AC, Kærn J, Flørenes VA, Kopolovic J, Tropé CG, et al. The AP-2γ transcription factor is upregulated in advanced-stage ovarian carcinoma. Gynecologic Oncology [Internet]. 2006;100(3):462–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-32644469278&doi=10.1016%252fj.ygyno.2005.09.022&partnerID=40&md5=029ee67960aed51b092f49d363975bc9

75.

Davidson B, Risberg B, Berner A, Bedrossian CWM, Reich R. The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma. Seminars in Diagnostic Pathology [Internet]. 2006;23(1):35–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748943120&doi=10.1053%252fj.semdp.2006.06.003&partnerID=40&md5=daf8db4574789bb9984da56c723f992d

76.

Puxeddu I, Bader R, Piliponsky AM, Reich R, Levi-Schaffer F, Berkman N. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts. Journal of Allergy and Clinical Immunology [Internet]. 2006;117(1):103–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-29544452289&doi=10.1016%252fj.jaci.2005.08.057&partnerID=40&md5=13c692b84685ad028f8b3c4ce102c5cf

77.

Tessone A, Feinberg MS, Barbash IM, Reich R, Holbova R, Richmann M, et al. Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction. Cardiovascular Drugs and Therapy [Internet]. 2005;19(6):383–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-32444441006&doi=10.1007%252fs10557-005-5201-6&partnerID=40&md5=46e48a73c991f8f7e7bf87c17497b8d3

78.

Reich R, Vintman L, Nielsen S, Kærn J, Bedrossian C, Berner A, et al. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities. Diagnostic Cytopathology [Internet]. 2005;33(5):332–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-27744567209&doi=10.1002%252fdc.20296&partnerID=40&md5=b1569a52a8da74eb5d5b3941cef14b07

79.

Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, et al. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Breast Cancer Research and Treatment [Internet]. 2005;94(1):71–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-26244439053&doi=10.1007%252fs10549-005-7328-3&partnerID=40&md5=ad47858f5fa5e2f0f6dfcb4bfc2cf001

80.

Cohen S, Katz Y, Reich R, Breuer E. Trans-(4-Methylcyclohexylcarbamoyl)phosphonic acid: A representative matrix metalloproteinase (MMP) inhibitor. Acta Crystallographica Section E: Structure Reports Online [Internet]. 2005;61(9):o3008–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33144480870&doi=10.1107%252fS1600536805025936&partnerID=40&md5=9b1661358bb5b06c80a20d53ee2f7849

81.

Haimov-Kochman R, Ravhon A, Prus D, Greenfield C, Finci-Yeheskel Z, Goldman-Wohl DS, et al. Expression and regulation of Sprouty-2 in the granulosa-lutein cells of the corpus luteum. Molecular Human Reproduction [Internet]. 2005;11(8):537–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-27144478902&doi=10.1093%252fmolehr%252fgah203&partnerID=40&md5=4848ecb0882c793b7362559764888d9c

82.

Schaner ME, Davidson B, Skrede M, Reich R, Flørenes VA, Risberg B, et al. Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients. Molecular Cancer [Internet]. 2005;4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-26844552461&doi=10.1186%252f1476-4598-4-26&partnerID=40&md5=5b2c35f4bdeec7621a378dd9f1224cb6

83.

Haimov-Kochman R, Prus D, Zcharia E, Goldman-Wohl DS, Natanson-Yaron S, Greenfield C, et al. Spatiotemporal expression of heparanase during human and rodent ovarian folliculogenesis. Biology of Reproduction [Internet]. 2005;73(1):20–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-20844457160&doi=10.1095%252fbiolreprod.104.036780&partnerID=40&md5=2b55aaeae0e6af8e52262065eca7af97

84.

Davidson B, Vintman L, Nielsen S, Reich R, Berner A. Site-related expression of metastasis-associated and signaling molecules in malignant mesothelioma - A new model for the study of tumor biology and disease progression. Lung Cancer [Internet]. 2005;49(SUPPL. 1):S89–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-20444423328&doi=10.1016%252fj.lungcan.2005.03.026&partnerID=40&md5=99b039a02e3a75d93fbc1d5de008605d

85.

Givant-Horwitz V, Davidson B, Reich R. Laminin-induced signaling in tumor cells. Cancer Letters [Internet]. 2005;223(1):1–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18844462417&doi=10.1016%252fj.canlet.2004.08.030&partnerID=40&md5=0836c2b3a2cbcafcf0230c7423710495

86.

Vintman L, Nielsen S, Berner A, Reich R, Davidson B. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells. Cancer [Internet]. 2005;103(11):2427–33. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18844401069&doi=10.1002%252fcncr.21014&partnerID=40&md5=4c6f400f7a3876ef435782544b59c515

87.

Reif S, Somech R, Brazovski E, Reich R, Belson A, Konikoff FM, et al. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C. Digestion [Internet]. 2005;71(2):124–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18744413561&doi=10.1159%252f000084626&partnerID=40&md5=a92f4dfa45fd0d47252eb29007ab10e5

88.

Reich R, Katz Y, Hadar R, Breuer E. Carbamoylphosphonate matrix metalloproteinase inhibitors 3: In vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis. Clinical Cancer Research [Internet]. 2005;11(10):3925–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18844424018&doi=10.1158%252f1078-0432.CCR-04-1985&partnerID=40&md5=255c2923633d6052c2a38b7b3482712d

89.

Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, et al. Snail, slug, and smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer [Internet]. 2005;103(8):1631–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-16844368863&doi=10.1002%252fcncr.20946&partnerID=40&md5=129970417476242948a8b8bcd86c3fe5

90.

Breuer E, Frant J, Reich R. Recent non-hydroxamate matrix metalloproteinase inhibitors. Expert Opinion on Therapeutic Patents [Internet]. 2005;15(3):253–69. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-15544373919&doi=10.1517%252f13543776.15.3.253&partnerID=40&md5=f2d67d2b7fa15cdf230e18b6dddd08d5

91.

Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond RL, et al. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2004;101(52):18081–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-19944428853&doi=10.1073%252fpnas.0407378102&partnerID=40&md5=6930e441c459d0e6e7f21a28f77c5ba5

92.

Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, et al. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: A novel model for tumor progression. Clinical Cancer Research [Internet]. 2004;10(21):7335–46. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-8444248590&doi=10.1158%252f1078-0432.CCR-04-0183&partnerID=40&md5=97a5f4c812da4e55124ff43452e8b4da

93.

Davidson B, Goldberg I, Tell L, Vigdorchik S, Baekelandt M, Berner A, et al. The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions. Clinical and Experimental Metastasis [Internet]. 2004;21(3):191–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4344600296&doi=10.1023%252fB%253aCLIN.0000037703.37275.35&partnerID=40&md5=a030f863e25a00df8a4d2c543e3ecd85

94.

Breuer E, Katz Y, Hadar R, Reich R. Carbamoylphosphonate MMP inhibitors. Part 4: The influence of chirality and geometrical isomerism on the potency and selectivity of inhibition. Tetrahedron Asymmetry [Internet]. 2004;15(15):2415–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4143137943&doi=10.1016%252fj.tetasy.2004.07.002&partnerID=40&md5=5748bdcaeb2a7f806497d41f188b8ae9

95.

Reif S, Aeed H, Shilo Y, Reich R, Kloog Y, Kweon YO, et al. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid. Journal of Hepatology [Internet]. 2004;41(2):235–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4444269015&doi=10.1016%252fj.jhep.2004.04.010&partnerID=40&md5=620447274b8419e18497404e1384b107

96.

Offen D, Gilgun-Sherki Y, Barhum Y, Benhar M, Grinberg L, Reich R, et al. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. Journal of Neurochemistry [Internet]. 2004;89(5):1241–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2642579050&doi=10.1111%252fj.1471-4159.2004.02428.x&partnerID=40&md5=459b8ce2144668a06bb190e141636d4e

97.

Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, et al. Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids. Journal of Medicinal Chemistry [Internet]. 2004;47(11):2826–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2442713986&doi=10.1021%252fjm030386z&partnerID=40&md5=c4aa46d66adbec3c60a7f74b9fc8e9f2

98.

Givant-Horwitz V, Davidson B, Reich R. Laminin-induced signaling in tumor cells: The role of the Mr 67,000 laminin receptor. Cancer Research [Internet]. 2004;64(10):3572–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2442711686&doi=10.1158%252f0008-5472.CAN-03-3424&partnerID=40&md5=07e409bdeb3ab5ff85f83e06125caeb4

99.

Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma. Gynecologic Oncology [Internet]. 2004;93(2):517–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1942444497&doi=10.1016%252fj.ygyno.2004.03.009&partnerID=40&md5=b6af6d2fe46440089f89c5a6d4e04c1e

100.

Davidson B, Reich R, Lazarovici P, Flørenes VA, Risberg B, Nielsen S, et al. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma. Lung Cancer [Internet]. 2004;44(2):159–65. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1842634536&doi=10.1016%252fj.lungcan.2003.11.014&partnerID=40&md5=fcd7f4981e5e8d0b426a9962c57e301d

101.

Ali HA, Berkovitz R, Reich R, Srebnik M. Matrix metallo-proteinase (MMP-2) organoboronate inhibitors. Archiv der Pharmazie [Internet]. 2004;337(4):183–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-3042741361&doi=10.1002%252fardp.200300827&partnerID=40&md5=91788dcabf664db1628e75b04e541be2

102.

Farkas E, Katz Y, Bhusare S, Reich R, Röschenthaler GV, Königsmann M, et al. Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: Solution studies and stability constants. Towards a zinc-selective binding group. Journal of Biological Inorganic Chemistry [Internet]. 2004;9(3):307–15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2342624494&doi=10.1007%252fs00775-004-0524-5&partnerID=40&md5=3b95d20c4ea8cf7579795fd8f58dfc42

103.

Reichenstein M, Reich R, Lehoux JG, Hanukoglu I. ACTH induces TIMP-1 expression and inhibits collagenase in adrenal cortex cells. Molecular and Cellular Endocrinology [Internet]. 2004;215(1–2):109–14. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542407821&doi=10.1016%252fj.mce.2003.11.011&partnerID=40&md5=ca85f99c8728eaabd4ca3a5710eda993

104.

Al-Quntar AAA, Baum O, Reich R, Srebnik M. Recently synthesized class of vinylphosphonates as potent matrix metalloproteinase (MMP-2) inhibitors. Archiv der Pharmazie [Internet]. 2004;337(2):76–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1642388464&doi=10.1002%252fardp.200300828&partnerID=40&md5=6adca3428ee01c52cf6f4ee215843935

105.

Flørenes VA, Mælandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B. Expression of activated TrkA protein in melanocytic tumors: Relationship to cell profileration and clinical outcome. American Journal of Clinical Pathology [Internet]. 2004;122(3):412–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4344645086&doi=10.1309%252fCHFHEYAT44WWP7J3&partnerID=40&md5=002a4c87d6ee3bd2b65402cf15089e1f

106.

Davidson B, Vintman L, Zcharia E, Bedrossian C, Berner A, Ielsen S, et al. Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma. Clinical and Experimental Metastasis [Internet]. 2004;21(5):469–76. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-12444255194&doi=10.1007%252fs10585-004-3150-2&partnerID=40&md5=853f31af083df5c4115787d2e0b26a05

107.

Davidson B, Reich R, Lazarovici P, Flørenes VA, Nielsen S, Nesland JM. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Research and Treatment [Internet]. 2004;83(2):119–28. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0742304068&doi=10.1023%252fB%253aBREA.0000010704.17479.8a&partnerID=40&md5=3e050e66974e785889c29db41ab10147

108.

Givant-Horwitz V, Davidson B, Van De Putte G, Dong HP, Goldberg I, Amir S, et al. Expression of the 67 kDa laminin receptor and the α6 integrin subunit in serous ovarian carcinoma. Clinical and Experimental Metastasis [Internet]. 2003;20(7):599–609. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0344873647&doi=10.1023%252fA%253a1027340208536&partnerID=40&md5=1bd5f8de38f3084522c13c03b7a10318

109.

Davidson B, Givant-Horwitz V, Lazarovici P, Risberg B, Nesland JM, Trope CG, et al. Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma. Clinical and Experimental Metastasis [Internet]. 2003;20(7):621–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0344441770&doi=10.1023%252fA%253a1027347932543&partnerID=40&md5=3da0bee9fbd0838bbd61e3606ed0194a

110.

Givant-Horwitz V, Davidson B, Lazarovici P, Schaefer E, Nesland JM, Tropé CG, et al. Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions. Gynecologic Oncology [Internet]. 2003;91(1):160–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141534435&doi=10.1016%2fS0090-8258%2803%2900434-7&partnerID=40&md5=0ec84f057c6bf31de5597e265f13a796

111.

Davidson B, Goldberg I, Reich R, Tell L, Dong HP, Trope’ CG, et al. αv- and β1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients. Gynecologic Oncology [Internet]. 2003;90(2):248–57. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042922958&doi=10.1016%2fS0090-8258%2803%2900321-4&partnerID=40&md5=9fd328e69f4ee59461b220cc7ca30784

112.

Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, et al. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clinical Cancer Research [Internet]. 2003;9(6):2248–59. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037500963&partnerID=40&md5=e45c3670d710f2af453260a0927c857c

113.

Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clinical and Experimental Metastasis [Internet]. 2003;20(2):161–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0344321892&doi=10.1023%252fA%253a1022696012668&partnerID=40&md5=4b6f4f5baec87363a23cb64dbcd6cbe1

114.

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma. Clinical Cancer Research [Internet]. 2003;9(4):1412–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037386973&partnerID=40&md5=8c607f92d210095371424a44790228a6

115.

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G, et al. Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: A possible activation pathway? Cancer and Metastasis Reviews [Internet]. 2003;22(1):103–15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037344825&doi=10.1023%252fA%253a1022272204045&partnerID=40&md5=6d48fc6d7f45029ed363e4010a0194d8

116.

Davidson B, Risberg B, Reich R, Berner A. Effusion cytology in ovarian cancer: New molecular methods as aids to diagnosis and prognosis. Clinics in Laboratory Medicine [Internet]. 2003;23(3):729–54. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141731370&doi=10.1016%2fS0272-2712%2803%2900058-1&partnerID=40&md5=c2971f6e68a7cc26bc320862c5582bee

117.

Davidson B, Goldberg I, Givant-Horwitz V, Nesland JM, Berner A, Bryne M, et al. Caveolin-1 expression in ovarian carcinoma is MDR1 independent. American Journal of Clinical Pathology [Internet]. 2002;117(2):225–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036328948&doi=10.1309%252fU40R-1BN4-6KJ3-BDG3&partnerID=40&md5=153ca0a816ed82727ce219c45e256c2b

118.

Danenberg HD, Fishbein I, Gao J, Mönkkönen J, Reich R, Gati I, et al. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation [Internet]. 2002;106(5):599–605. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037199425&doi=10.1161%252f01.CIR.0000023532.98469.48&partnerID=40&md5=00eda74a813eb2a913af1adb89b6cd4c

119.

Garbuzenko E, Nagler A, Pickholtz D, Gillery P, Reich R, Maquart FX, et al. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: A direct role for mast cells in skin fibrosis. Clinical and Experimental Allergy [Internet]. 2002;32(2):237–46. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036229053&doi=10.1046%252fj.1365-2222.2002.01293.x&partnerID=40&md5=ab79dd4dabb7b8429c8b8f1b0f0f135b

120.

Pergament I, Reich R, Srebnik M. Novel matrix metallo-proteinase (MMP-2) phosphonoboronate inhibitors. Bioorganic and Medicinal Chemistry Letters [Internet]. 2002;12(8):1215–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037156351&doi=10.1016%2fS0960-894X%2802%2900110-5&partnerID=40&md5=cafacc2c5937f1771062921ac06b2d78

121.

Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, et al. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions. Clinical and Experimental Metastasis [Internet]. 2002;19(2):135–44. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036202096&doi=10.1023%252fA%253a1014582911680&partnerID=40&md5=1d6796212e6c1a822b6db22cddfafa8d

122.

Wormser U, Brodsky B, Reich R. Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity. Archives of Toxicology [Internet]. 2002;76(2):119–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036202260&doi=10.1007%252fs00204-001-0307-5&partnerID=40&md5=b519ae5ae15c78a8d614d6f2f9da82c5

123.

Alpert E, Gruzman A, Totary H, Kaiser N, Reich R, Sasson S. A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: Role of glucose and 12-hydroxyeicosatetraenoic acid. Biochemical Journal [Internet]. 2002;362(2):413–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036499692&doi=10.1042%252f0264-6021%253a3620413&partnerID=40&md5=a8ff11217fc7cc91c5beb40f889985af

124.

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, et al. The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Molecular and Cellular Endocrinology [Internet]. 2002;187(1–2):39–45. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037154991&doi=10.1016%2fS0303-7207%2801%2900709-2&partnerID=40&md5=d5f3c38af0be172c7315a5a5bc063423

125.

Davidson B, Reich R, Risberg B, Nesland JM. The biological role and regulation of matrix metalloproteinases (MMP) in cancer. Arkhiv patologii [Internet]. 2002;64(3):47–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-7944236463&partnerID=40&md5=aac72eb479ae181c969f183589d951b4

126.

Fiucci G, Ravid D, Reich R, Liscovitch M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene [Internet]. 2002;21(15):2365–75. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037018405&doi=10.1038%252fsj.onc.1205300&partnerID=40&md5=c7d103d25c35adf0bbfac0ba15880b1c

127.

Margolin L, Fishbein I, Banai S, Golomb G, Reich R, Perez LS, et al. Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: Augmentative effect of αvβ3 receptor blockade. Atherosclerosis [Internet]. 2002;163(2):269–77. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036275380&doi=10.1016%2fS0021-9150%2802%2900035-7&partnerID=40&md5=7f71d59074ca554ca7dcf5fe254afcf8

128.

Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Tropé CG, et al. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome. American Journal of Surgical Pathology [Internet]. 2001;25(12):1493–500. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035179075&doi=10.1097%252f00000478-200112000-00004&partnerID=40&md5=27c9e28ef548195df1588cdc9ad1cf00

129.

Davidson B, Reich R, Berner A, Givant-Horwitz V, Goldberg I, Risberg B, et al. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels. European Journal of Cancer [Internet]. 2001;37(16):2040–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034779239&doi=10.1016%2fS0959-8049%2801%2900235-0&partnerID=40&md5=df69a2c1bc88b683b1b2603ee34a67cf

130.

Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2001;98(11):6162–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035932991&doi=10.1073%252fpnas.101130898&partnerID=40&md5=3725c5af64df731c5d6abb504cb35ad9

131.

Even-Ram SC, Maoz M, Pokroy E, Reich R, Katz BZ, Gutwein P, et al. Tumor Cell Invasion Is Promoted by Activation of Protease Activated Receptor-1 in Cooperation with the αvβ5 Integrin. Journal of Biological Chemistry [Internet]. 2001;276(14):10952–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035815711&doi=10.1074%252fjbc.M007027200&partnerID=40&md5=5736e12234ba2604c53d8845120cb4b5

132.

Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M, et al. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. American Journal of Clinical Pathology [Internet]. 2001;115(4):517–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17744394053&doi=10.1309%252fB1YX-L8DB-TGY1-7905&partnerID=40&md5=578e48dfb24128dbeb54339bd0a96e5f

133.

Goldberg I, Kopolovic J, Gotlieb WH, Ben-Baruch G, Davidson B, Berner A, et al. αv integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma. Clinical Cancer Research [Internet]. 2001;7(12):4073–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035542949&partnerID=40&md5=61e66b17cbe239b3a8a033f34507f481

134.

Davidson B, Nesland JM, Berner A, Risberg B, Goscinski M, Tropé CG, et al. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Clinical Cancer Research [Internet]. 2001;7(11):3457–64. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035191001&partnerID=40&md5=f017ab99b58be780b7b8662e5d5d69f1

135.

Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, et al. Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathologic study. Gynecologic Oncology [Internet]. 2001;81(2):166–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035011210&doi=10.1006%252fgyno.2001.6156&partnerID=40&md5=2f10b280d010732b935e4bb5edeba790

136.

Davidson B, Berner A, Nesland JM, Davidson B, Berner A, Nesland JM, et al. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clinical Cancer Research [Internet]. 2001;7(3):551–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034907329&partnerID=40&md5=69702ca704a9cd7f0e602ec19252aceb

137.

Sasson S, Davarashvili A, Reich R. Role of lipoxygenase in the regulation of glucose transport in aortic vascular cells. Advances in Experimental Medicine and Biology [Internet]. 2000;469:377–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034463253&partnerID=40&md5=221bdda4a23325252f235d72e30722ef

138.

Davidson B, Goldberg I, Kopolovic J, Gotlieb WH, Givant-Horwitz V, Nesland JM, et al. Expression of angiogenesis-related genes in ovarian carcinoma - A clinicopathologic study. Clinical and Experimental Metastasis [Internet]. 2000;18(6):501–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034843631&doi=10.1023%252fA%253a1011858225144&partnerID=40&md5=7696444202c900c54e07bf4c04903382

139.

Elkin M, Miao HQ, Nagler A, Aingorn E, Reich R, Hemo I, et al. Halofuginone: A potent inhibitor of critical steps in angiogenesis progression. FASEB Journal [Internet]. 2000;14(15):2477–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033664318&doi=10.1096%252ffj.00-0292com&partnerID=40&md5=871f11a4fbf862de236f6ed8b8e428e5

140.

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, et al. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clinical and Experimental Metastasis [Internet]. 1999;17(10):799–808. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033762457&doi=10.1023%252fA%253a1006723011835&partnerID=40&md5=d27fb2c3d06b5e453ce24c78eae439aa

141.

Levi-Schaffer F, Garbuzenko E, Rubin A, Reich R, Pickholz D, Gillery P, et al. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: A role for transforming growth factor β (TGF-β). Proceedings of the National Academy of Sciences of the United States of America [Internet]. 1999;96(17):9660–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033578319&doi=10.1073%252fpnas.96.17.9660&partnerID=40&md5=f347941df9ff718a4654276dd7e7fb7f

142.

Elkin M, Reich R, Nagler A, Aingorn E, Pines M, De-Groot N, et al. Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone. Clinical Cancer Research [Internet]. 1999;5(8):1982–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032787282&partnerID=40&md5=a46bdb1fa88840de3ee53fd56e9d9595

143.

Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, et al. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - A clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecologic Oncology [Internet]. 1999;73(3):372–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033019235&doi=10.1006%252fgyno.1999.5381&partnerID=40&md5=5820cdbb51bab081dd6434368377a8dd

144.

Tsafriri A, Reich R. Molecular aspects of mammalian ovulation. Experimental and Clinical Endocrinology and Diabetes [Internet]. 1999;107(1):1–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033002287&doi=10.1055%252fs-0029-1212066&partnerID=40&md5=ec4b82e1d2586fd797596984f595754d

145.

Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Weis B, et al. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix - Clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecologic Oncology [Internet]. 1999;72(3):380–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032981670&doi=10.1006%252fgyno.1998.5285&partnerID=40&md5=0eda755dde798fa91aeae808d97f4a1b

146.

Migdal M, Huppertz B, Tessler S, Comforti A, Shibuya M, Reich R, et al. Neuropilin-1 is a placenta growth factor-2 receptor. Journal of Biological Chemistry [Internet]. 1998;273(35):22272–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032575576&doi=10.1074%252fjbc.273.35.22272&partnerID=40&md5=138a390233d6ca93af5d4b02383f6839

147.

Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Medicine [Internet]. 1998;4(8):909–14. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031927754&doi=10.1038%252fnm0898-909&partnerID=40&md5=b97649232c39c51d112e12da165f629d

148.

Abramovitch R, Neeman M, Reich R, Stein I, Keshet E, Abraham J, et al. Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Letters [Internet]. 1998;425(3):441–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032478654&doi=10.1016%2fS0014-5793%2898%2900283-X&partnerID=40&md5=4df492b654db5e3e970fe4c9784aa7db

149.

Dinney CPN, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, et al. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-α administration. Cancer Research [Internet]. 1998;58(4):808–14. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032519590&partnerID=40&md5=1759a522ca502a999ceb68a7d20666d8

150.

Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, et al. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix. International Journal of Gynecological Pathology [Internet]. 1998;17(4):295–301. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031716731&doi=10.1097%252f00004347-199810000-00002&partnerID=40&md5=8f8340d8dbd8eaeacf948397b0363e2e

151.

Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. American Journal of Pathology [Internet]. 1997;151(4):1105–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030777119&partnerID=40&md5=bc8a658a9c75eeaf644e78f94004185f

152.

Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Research [Internet]. 1997;57(11):2295–303. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030913615&partnerID=40&md5=df5e462fe33629daf20000a801813b99

153.

Sasson S, Kredy-Farahan L, Kaiser N, Reich R. Bovine vascular cells and extracellular matrix interactions: Dual effect of hyperglycemia. Experimental and Clinical Endocrinology and Diabetes [Internet]. 1997;105(SUPPL. 3):54–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1942457220&doi=10.1055%252fs-0029-1211876&partnerID=40&md5=421274b118b8c90a58ba6ae0c4186e4a

154.

Singh RK, Reich R, Radinsky R, Berry KK, Dave BJ, Fidler IJ. Expression of basic fibroblast growth factor is necessary but insufficient for production of metastasis. International Journal of Oncology [Internet]. 1997;10(1):23–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031024414&doi=10.3892%252fijo.10.1.23&partnerID=40&md5=c83e36bb9d7220541d0872ce27b26bf2

155.

Tsafrin A, Reich R. Tissue remodeling in ovulation: Molecular regulation. Gynecological Endocrinology [Internet]. 1996;10(SUPPL. 4):61–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79961086760&doi=10.3109%252f09513599609116189&partnerID=40&md5=4b6289e99d0afe5236860563a02f7569

156.

Reich R, Martin GR. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins [Internet]. 1996;51(1):1–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0041590826&doi=10.1016%2f0090-6980%2895%2900154-9&partnerID=40&md5=6219d847c4eafcd8a0497eadd4d27daf

157.

Williger BT, Reich R, Neeman M, Bercovici T, Liscovitch M. Release of gelatinase A (matrix metalloproteinase 2) induced by photolysis of caged phosphatidic acid in HT 1080 metastatic fibrosarcoma cells. Journal of Biological Chemistry [Internet]. 1995;270(50):29656–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029563161&doi=10.1074%252fjbc.270.50.29656&partnerID=40&md5=258dc2af23537786f9f4ddae4ac7b33a

158.

Singh RK, Gutman M, Reich R, Bar-Eli M. Ultraviolet B Irradiation Promotes Tumorigenic and Metastatic Properties in Primary Cutaneous Melanoma via Induction of Interleukin 8. Cancer Research [Internet]. 1995;55(16):3669–74. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029102881&partnerID=40&md5=6e3f484c86cb9811a8f080beec433e75

159.

Reich R, Blumenthal M, Liscovitch M. Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells. Clinical & Experimental Metastasis [Internet]. 1995;13(2):134–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028957571&doi=10.1007%252fBF00133618&partnerID=40&md5=eba6c5987b5ad8faa6c0999f29e96f13

160.

Iwamoto Y, Reich R, Nemeth G, Yamada Y, Martin GR. Cyclic AMP decreases chemotaxis, invasiveness and lung colonization of H-ras transformed mouse fibroblasts. Clinical & Experimental Metastasis [Internet]. 1993;11(6):492–501. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027446660&doi=10.1007%252fBF00054940&partnerID=40&md5=49bfbad510892c6a7bf61649f9af3651

161.

Yagel S, Geva TE, Solomon H, Shimonovitz S, Reich R, Finci-Yeheskel Z, et al. High levels of human chorionic gonadotropin retard first trimester trophoblast invasion in vitro by decreasing urokinase plasminogen activator and collagenase activities. Journal of Clinical Endocrinology and Metabolism [Internet]. 1993;77(6):1506–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027143633&doi=10.1210%252fjcem.77.6.8263134&partnerID=40&md5=6eedd0ce7de6a5a37b3e7e5eafb8973c

162.

Hirsch B, Leonhardt S, Jarry H, Reich R, Tsafriri A, Wuttke W. In vivo measurement of rat ovarian collagenolytic activities. Endocrinology [Internet]. 1993;133(6):2761–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027138086&doi=10.1210%252fendo.133.6.8243302&partnerID=40&md5=59cade7d8188330ded7a4b03a89df9b3

163.

Young CS, Reich R, Spiess S, Pitzel L, Wuttke W, Tsafriri A. Localization of interstitial collagenase gene expression in gilt preovulatory follicles. Endocrine [Internet]. 1993;1(6):481–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027138022&partnerID=40&md5=bb051493dafc4ea2dd3a25b8543e026b

164.

Chun SY, Popliker M, Reich R, Tsafriri A. Localization of preovulatory expression of plasminogen activator inhibitor type-1 and tissue inhibitor of metalloproteinase type-1 mRNAs in the rat ovary. Biology of Reproduction [Internet]. 1992;47(2):245–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026773759&doi=10.1095%252fbiolreprod47.2.245&partnerID=40&md5=7518c0daf32c5b27f060a27713bf89bf

165.

Brodt P, Reich R, Moroz LA, Chambers AF. Differences in the repertoires of basement membrane degrading enzymes in two carcinoma sublines with distinct patterns of site-selective metastasis. BBA - Molecular Basis of Disease [Internet]. 1992;1139(1–2):77–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026697317&doi=10.1016%2f0925-4439%2892%2990085-2&partnerID=40&md5=7a22ef3f9fa4f994241026ca586d4e6d

166.

Pluznik DH, Fridman R, Reich R. Correlation in the expression of type IV collagenase and the invasive and chemotactic abilities of mylomonocytic cells during differentiation into macrophages. Experimental Hematology [Internet]. 1992;20(1):57–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026570208&partnerID=40&md5=376e4f5e35e027be8bb9f7c42c0fc58e

167.

Kranzfelder D, Reich R, Abisogun AO, Tsafriri A. Preovulatory changes in the perifollicular capillary network in the rat: Role of eicosanoids. Biology of Reproduction [Internet]. 1992;46(3):379–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026553409&doi=10.1095%252fbiolreprod46.3.379&partnerID=40&md5=7699b94b273ba841af3b91486ecb51ef

168.

Reich R, Daphna-Iken D, Chun SY, Popliker M, Slager R, Adelmann-Grill BC, et al. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: Role of eicosanoids. Endocrinology [Internet]. 1991;129(4):1869–75. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026049429&doi=10.1210%252fendo-129-4-1869&partnerID=40&md5=e7f2bb6a7c074f563ac61ee9308b4306

169.

Frisch SM, Reich R, Collier IE, Genrich LT, Martin B, Goldberg GI. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene [Internet]. 1990;5(1):75–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025008680&partnerID=40&md5=ad1eeaeb56bcd3e31421f904f0eda9c9

170.

GOLDBERG GI, FRISCH SM, HE C, WILHELM SM, REICH R, COLLIER IE. Secreted Proteases: Regulation of Their Activity and Their Possible Role in Metastasis. Annals of the New York Academy of Sciences [Internet]. 1990;580(1):375–84. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025295127&doi=10.1111%252fj.1749-6632.1990.tb17945.x&partnerID=40&md5=fb84937af9c334a8b598f904df413fb4

171.

Kanemoto T, Reich R, Royce L, Greatorex D, Adler SH, Shiraishi N, et al. Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 1990;87(6):2279–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025240522&doi=10.1073%252fpnas.87.6.2279&partnerID=40&md5=1f41de91cf721f0d615f47463db196d9

172.

Fridman R, Scott AF, Muller D, Reich R, Penno MB. The role of cell adhesion and migration in the in vitro invasiveness of mouse adrenal carcinoma cells. Invasion and Metastasis [Internet]. 1990;10(4):208–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025185472&partnerID=40&md5=301e1e0bc9ccaff56952a5012d07d808

173.

Fridman R, Lacal JC, Reich R, Bonfil DR, Ahn C ‐H. Differential effects of phorbol ester on the in vitro invasiveness of malignant and non‐malignant human fibroblast cells. Journal of Cellular Physiology [Internet]. 1990;142(1):55–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025157624&doi=10.1002%252fjcp.1041420108&partnerID=40&md5=5f94bca219433614cdf8404bd37483ab

174.

Sank AC, Chi M, Shima T, Reich R, Martin GR. Collagenase and PDGF modulate chronic wound repair. Surgical Forum [Internet]. 1989;40:624–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024918704&partnerID=40&md5=048d6cf82b937ccb0b7b958ccb2dc752

175.

Bonfil RD, Momiki S, Fridman R, Reich R, Reddel R, Harris CC, et al. Enhancement of the invasive ability of a transformed human bronchial epithelial cell line by 12-o-tetra-decanoyl-phorbol-13-acetate and diacylglycerol. Carcinogenesis [Internet]. 1989;10(12):2335–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024367971&doi=10.1093%252fcarcin%252f10.12.2335&partnerID=40&md5=ea3a572224938c8097a301837bc61384

176.

Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC, et al. Expression of Type IV Collagenase and Procollagen Genes and Its Correlation with the Tumorigenic, Invasive, and Metastatic Abilities of Oncogene-transformed Human Bronchial Epithelial Cells. Cancer Research [Internet]. 1989;49(16):4615–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024344882&partnerID=40&md5=6740af31ce0b0d4f9c8a662809669083

177.

Reich R, Royce L, Martin GR. Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells. Biochemical and Biophysical Research Communications [Internet]. 1989;160(2):559–64. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024403259&doi=10.1016%2f0006-291X%2889%2992469-8&partnerID=40&md5=d54727de0d30da4708171fc8c182ea06

178.

Bonfil RD, Reddel RR, Ura H, Reich R, Fridman R, Harris CC, et al. Invasive and metastatic potential of a v-ha-ras-transformed human bronchial epithelial cell line. Journal of the National Cancer Institute [Internet]. 1989;81(8):587–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024555949&doi=10.1093%252fjnci%252f81.8.587&partnerID=40&md5=dfdbf5d720524e7a26bbe0022881e625

179.

Axelrod JH, Reich R, Miskin R. Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells. Molecular and Cellular Biology [Internet]. 1989;9(5):2133–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024556819&doi=10.1128%252fMCB.9.5.2133&partnerID=40&md5=75b81738400237f6259462c92aa38f8b

180.

Sank A, Chi M, Shima T, Reich R, Martin GR. Increased calcium levels alter cellular and molecular events in wound healing. Surgery [Internet]. 1989;106(6):1141–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024306575&partnerID=40&md5=ec39fe6d8f0f8a5b5ef706833bd537a3

181.

Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, et al. Differential Regulation of Growth and Invasiveness of MCF-7 Breast Cancer Cells by Antiestrogens. Cancer Research [Internet]. 1988;48(23):6764–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024210084&partnerID=40&md5=c0e01fcbf83644e00ad5fea81934b358

182.

Reich R, Stratford B, Klein K, Martin GR, Mueller RA, Fuller GC. Inhibitors of collagenase IV and cell adhesion reduce the invasive activity of malignant tumour cells. Ciba Foundation symposium [Internet]. 1988;141:193–210. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024201509&partnerID=40&md5=fac27175e2c39e0c588eeafd799cc5ad

183.

Thompson EW, Reich R, Martin GR, Albini A. Factors regulating basement membrane invasion by tumor cells. Cancer treatment and research [Internet]. 1988;40:239–49. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024154598&doi=10.1007%252f978-1-4613-1733-3_11&partnerID=40&md5=d8eddde4937b9df615ad9dacae00afde

184.

Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, et al. Effects of Inhibitors of Plasminogen Activator, Serine Proteinases, and Collagenase IV on the Invasion of Basement Membranes by Metastatic Cells. Cancer Research [Internet]. 1988;48(12):3307–12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023919232&partnerID=40&md5=ab0a919ad078a01b63568e2d8ea60371

185.

Abisogun AO, Daphna-Iken D, Reich R, Kranzfelder D, Tsafriri A. Modulatory role of eicosanoids in vascular changes during the preovulatory period in the rat. Biology of Reproduction [Internet]. 1988;38(4):756–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023814783&doi=10.1095%252fbiolreprod38.4.756&partnerID=40&md5=0e8b7e0b5c7c55bd64020afc4ad0ce55

186.

Tsafriri A, Abisogun AO, Reich R. Steroids and follicular rupture at ovulation. Journal of Steroid Biochemistry [Internet]. 1987;27(1–3):359–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023577690&doi=10.1016%2f0022-4731%2887%2990328-1&partnerID=40&md5=461f5e4ae8fd144bc2824f437c12cf92

187.

Feldman E, Haberman S, Abisogun AO, Reich R, Levran D, Maschiach S, et al. Arachidonic acid metabolism in human granulosa cells: Evidence for cyclooxygenase and lipoxygenase activity in vitro. Human Reproduction [Internet]. 1986;1(6):353–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023032366&doi=10.1093%252foxfordjournals.humrep.a136422&partnerID=40&md5=fbaff81eef230867abb65b04ea49d836

188.

Reich R, Miskin R, Tsafriri A. Intrafollicular distribution of plasminogen activators and their hormonal regulation in vitro. Endocrinology [Internet]. 1986;119(4):1588–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022996319&doi=10.1210%252fendo-119-4-1588&partnerID=40&md5=0aa9bf8aa68653015488171910b3a49d

189.

Reich R, Kohen F, Slager R, Tsafriri A. Ovarian lipoxygenase activity and its regulation by gonadotropin in the rat. Prostaglandins [Internet]. 1985;30(4):581–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022359816&doi=10.1016%2f0090-6980%2885%2990022-X&partnerID=40&md5=20b4307b95d0f679b5482101f1231109

190.

Reich R, Miskin R, Tsafriri A. Follicular plasminogen activator: Involvement in ovulation. Endocrinology [Internet]. 1985;116(2):516–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021996803&doi=10.1210%252fendo-116-2-516&partnerID=40&md5=d4ca6c908fc7f518c53bacd744bf30d3

191.

Reich R, Tsafriri A, Mechanic GL. The involvement of collagenolysis in ovulation in the rat. Endocrinology [Internet]. 1985;116(2):522–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021970315&doi=10.1210%252fendo-116-2-522&partnerID=40&md5=cec0f31a250c646b42b0c95b3ca77005

192.

Reich R, Kohen F, Naor Z, Tsafriri A. Possible involvement of lipoxygenase products of arachidonic acid pathway in ovulation. Prostaglandins [Internet]. 1983;26(6):1011–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021021839&doi=10.1016%2f0090-6980%2883%2990161-2&partnerID=40&md5=8401e96fcc52add00687637e3f4c7f88

193.

Laufer N, Reich R, Braw R, Shenker JG, Tsafriri A. Effect of clomiphene citrate on preovulatory rat follicles in culture. Biology of Reproduction [Internet]. 1982;27(2):463–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020371362&doi=10.1095%252fbiolreprod27.2.463&partnerID=40&md5=67f8d5a2270c06025a904915b4009add

194.

Reich R, Laufer N, Lewysohn O, Cordova T, Ayalon D, Tsafriri A. In vitro effects of cannabinoids on follicular function in the rat. Biology of Reproduction [Internet]. 1982;27(1):223–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019941486&doi=10.1095%252fbiolreprod27.1.223&partnerID=40&md5=c249ccdd427335a7aa61bca7b6f83b7a

195.

Ben-Jonathan N, Braw RH, Laufer N, Reich R, Bahr JM, Tsafriri A. Norepinephrine in graafian follicles is depleted by follicle-stimulating hormone. Endocrinology [Internet]. 1982;110(2):457–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020055351&doi=10.1210%252fendo-110-2-457&partnerID=40&md5=c9ad2a8c3c8ade4bffe6bfc2b411462b